[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients paraneoplastic neurological syndrome and anti-Hu antibodies

Annals of Neurology

Volumn 48, Issue 1, 2000, Pages 105-108

  Antoine, J C ^a   Cinotti, L ^b   Tilikete, C ^b   Bouhour, F ^b   Camdessanche J P ^a   Confavreux, C ^b   Vighetto, A ^b   Renault Mannel, V ^b   Michel, D ^a   Honnorat, J ^b  

^a SERVICE DE NEUROLOGIE   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G; PROTEIN; HU ANTIGEN; NERVE PROTEIN; RNA BINDING PROTEIN;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; THORAX RADIOGRAPHY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED; SCINTISCANNING;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES; RNA-BINDING PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033623826     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO;2-G     Document Type: Article

References (13)

1. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1991;71:59-72
2. Luchinetti CF, Kimmel DW, Lennon V. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear antibodies. Neurology 1998;50:652-657
3. Moll JWB, Antoine JC, Brashear HR, et al. Guidelines on the detection of paraneoplastic anti-neuronal antibodies. Neurology 1995;45:1937-1941
4. Chartran-Lefebvre C, Howarth HN, Grenier P, et al. Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiological and CT findings. AJR Am J Roentgenol 1998;170:1513-1517
5. Molinuevo JL, Graus F, Serrano C, et al. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 1998;44:976-980
6. Graus F, Dalmau J, Rene R, et al. Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997; 15:2866-2872
7. Mason WP, Graus F, Lang B, et al. Small cell lung cancer, paraneoplastic cerebellar degeneration, and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300
8. Keime-Guibert F, Graus F, Broet P, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-1723
9. Duhaylongsod FG, Lowe VJ, Patz EF Jr, et al. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-1352
10. Sazon DA, Santiago SM, Soo Hoc GW, et al. Fluorodeoxy-glucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996;153: 417-421
11. Chin R Jr, Ward R, Keyes JW, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995;152:2090-2106
12. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-1581
13. Knight SB, Delbeke D, Stewart JR, et al. Evaluation of pulmo nary lesions with FDG-PET: comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109:982-988